About Dashenlin Pharmaceutical Group
Dashenlin Pharmaceutical Group was established in 1999 and is headquartered in Guangzhou, China. Operations are focused on the pharmaceutical sector, where diversified generic drugs are produced for multiple therapeutic categories. Manufacturing processes are conducted to meet regulatory standards in the generics industry. The companys online presence is maintained through dslyy.com, supporting distribution and information access across domestic and potential international markets.
- Headquarter Guangzhou, China
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
$3.61 B (USD)7.94as on Dec 31, 2024
-
Net Profit
$125.32 M (USD)-21.58as on Dec 31, 2024
-
EBITDA
$468.53 M (USD)-1.43as on Dec 31, 2024
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Dashenlin Pharmaceutical Group
Detailed funding history for Dashenlin Pharmaceutical Group
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Dashenlin Pharmaceutical Group
Investment portfolio details for Dashenlin Pharmaceutical Group
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Dashenlin Pharmaceutical Group
Detailed financials for Dashenlin Pharmaceutical Group
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Dashenlin Pharmaceutical Group Comparisons
Peer comparison for Dashenlin Pharmaceutical Group
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Dashenlin Pharmaceutical Group
Detailed competitors of Dashenlin Pharmaceutical Group
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Dashenlin Pharmaceutical Group
Complete news archive for Dashenlin Pharmaceutical Group
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dashenlin Pharmaceutical Group
Dashenlin Pharmaceutical Group was founded in 1999.
Dashenlin Pharmaceutical Group is headquartered in Guangzhou, China. It is registered at Guangzhou, Guangdong, China.
Annual revenue of Dashenlin Pharmaceutical Group is $3.61B as on Dec 31, 2024.
Dashenlin Pharmaceutical Group was established in 1999 and is headquartered in Guangzhou, China. Operations are focused on the pharmaceutical sector, where diversified generic drugs are produced for multiple therapeutic categories. Manufacturing processes are conducted to meet regulatory standards in the generics industry. The companys online presence is maintained through dslyy.com, supporting distribution and information access across domestic and potential international markets.